CPI-169
≥96%
- Product Code: 100192
CAS:
1802175-07-0
| Molecular Weight: | 528.66 g./mol | Molecular Formula: | C₂₇H₃₆N₄O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
CPI-169 is primarily utilized in research settings, particularly in the study of cancer biology and signal transduction pathways. It functions as a potent and selective inhibitor of VEGFR2 (Vascular Endothelial Growth Factor Receptor 2), which plays a critical role in angiogenesis, the process by which new blood vessels form from pre-existing vessels. By inhibiting VEGFR2, CPI-169 helps researchers understand the mechanisms of tumor growth and metastasis, as angiogenesis is essential for supplying nutrients and oxygen to cancerous tissues. This compound is also valuable in preclinical studies aimed at developing novel anti-cancer therapies, as it provides insights into the potential efficacy of targeting angiogenesis to halt tumor progression. Additionally, CPI-169 is used in biochemical assays to explore the downstream signaling pathways activated by VEGFR2, contributing to a deeper understanding of cellular responses and potential therapeutic targets in various diseases.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | ฿23,931.00 |
+
-
|
| 0.005 | 10-20 days | ฿35,910.00 |
+
-
|
CPI-169
CPI-169 is primarily utilized in research settings, particularly in the study of cancer biology and signal transduction pathways. It functions as a potent and selective inhibitor of VEGFR2 (Vascular Endothelial Growth Factor Receptor 2), which plays a critical role in angiogenesis, the process by which new blood vessels form from pre-existing vessels. By inhibiting VEGFR2, CPI-169 helps researchers understand the mechanisms of tumor growth and metastasis, as angiogenesis is essential for supplying nutrients and oxygen to cancerous tissues. This compound is also valuable in preclinical studies aimed at developing novel anti-cancer therapies, as it provides insights into the potential efficacy of targeting angiogenesis to halt tumor progression. Additionally, CPI-169 is used in biochemical assays to explore the downstream signaling pathways activated by VEGFR2, contributing to a deeper understanding of cellular responses and potential therapeutic targets in various diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :